Improving Human and Animal Health With Protein Engineering.


Design of recombinant proteins with desired properties initially became possible in 1982 with the publishing of the first mutagenesis studies. In these past thirty years, however, successful examples of protein engineering have been rare. Our technology represents the first successful design of super active analogs of glycoprotein hormones that shows major increases in bioactivity and far exceeds results shown for other protein ligands. PDF version here.


Status of Long Acting, Superagonist Human/Animal Product Pipeline


Trophogen Inc. 2014